Rx Product News (February 2019)

SYMJEPIMANUFACTURED BY: Sandoz Inc

INDICATION: Novartis’ Sandoz division is introducing Symjepi (epinephrine) in the US market. The 0.3-mg injections are indicated for the emergency treatment of anaphylactic allergic reactions. The injection works by reducing swelling in the airway and preventing fatal reactions to drugs, food, insect bites and stings, and other substances that induce anaphylaxis. The German drug company is expanding to bring an affordable option of a pre-filled, single-dose auto-injector to US patients.

DOSAGE FORM: Auto-injector device

FOR MORE INFORMATION: sandoz.com

TRUVADA

MANUFACTURED BY: Gilead Sciences

INDICATION: Recently, Gilead announced new data on the effect of Truvada (emtricitabine and tenofovir disoproxil fumarate) and its ability to prevent HIV infection through preexposure prophylaxis (PrEP). Study results show that states with the highest use of Truvada as PrEP significantly reduced the rate of new HIV infections. People at risk for HIV who are not infected can take Truvada, in addition to practicing safe sex, to prevent HIV infection. Truvada can also treat HIV infections and prevent AIDS progression when taken with other HIV drugs.

DOSAGE FORM: Tablets

FOR MORE INFORMATION: truvada.com

BIKTARVY

MANUFACTURED BY: Gilead Sciences

INDICATION: Biktarvy (bictegravir 50mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg) is a once-a-day prescription medication that combines 3 HIV medicines into 1 convenient pill. The drug is indicated for patients who test positive for HIV and have never taken HIV drugs before or have had an undetectable viral load for at least 3 months on their current treatment. Biktarvy can help patients achieve an undetectable viral load and increase the number of CD4 T cells in the blood.

DOSAGE FORM: Tablets

FOR MORE INFORMATION: biktarvy.com

FIRST-METOPROLOL COMPOUNDING KIT

MANUFACTURED BY: CutisPharma

INDICATION: FIRST Metoprolol Compounding Kit (metoprolol tartrate 10 mg/ml) is a prescription-only solution with step-by-step compounding instructions for easy use. The compound is indicated for the treatment of ischemic heart disease, a disease where coronary arteries are blocked, preventing adequate blood supply to the bodies organs, resulting in tissue death. The compound helps promote blood flow while reducing symptoms of heart disease, such as cardiomyopathy, chest pain, heart attacks, high blood pressure, and irregular or rapid heartbeats.

DOSAGE FORM: Oral solution

FOR MORE INFORMATION: cutispharma.com